Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: CLDI )

2.320 -0.170 (-6.83%)
Official Closing Price Updated: 6:30 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,866
Open 2.400
Bid (Size) 2.280 (1)
Ask (Size) 2.400 (2)
Prev. Close 2.490
Today's Range 2.280 - 2.440
52wk Range 1.500 - 5.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones
From Calidi Biotherapeutics, Inc.
Via Business Wire
Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results
From Calidi Biotherapeutics, Inc.
Via Business Wire

Performance

YTD
-52.65%
-52.65%
1 Month
+16.00%
+16.00%
3 Month
-52.65%
-52.65%
6 Month
-52.65%
-52.65%
1 Year
-52.65%
-52.65%

More News

Read More
Calidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023)
From Calidi Biotherapeutics, Inc.
Via Business Wire
Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment
From Calidi Biotherapeutics, Inc.
Via Business Wire
Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer
From Calidi Biotherapeutics, Inc.
Via Business Wire
Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023
From Calidi Biotherapeutics, Inc.
Via Business Wire
Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023
Via Benzinga
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Turns Lower; KULR Technology Group Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Gains 50 Points; US Crude Oil Inventories Rise
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Nasdaq Gains 50 Points; US Inflation Rate Rises In August
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.